Results 151 to 160 of about 119,805 (200)

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response. [PDF]

Front Immunol
Ning W, Yan S, Song Y, Xu H, Zhang J, Wang X.   +5 more
europepmc   +1 more source

Virus-like particle vaccine with authentic quaternary epitopes protects against Zika virus-induced viremia and testicular damage. [PDF]

J Virol
Abbo SR, Yan K, Geertsema C, Hick TAH, Altenburg JJ, Nowee G, van Toor C, van Lent JW, Nakayama E, Tang B, Metz SW, Bhowmik R, de Silva AM, Prow NA, Correia R, Alves PM, Roldão A, Martens DE, van Oers MM, Suhrbier A, Pijlman GP.   +20 more
europepmc   +1 more source

Electromagnetic waves destabilize the SARS-CoV-2 Spike protein and reduce SARS-CoV-2 Virus-Like particle (SC2-VLP) infectivity. [PDF]

Sci Rep
Pantoja C, Acosta FM, Granatir S, Anderson M, Wyr M, Tailor J, Fuori A, Dower W, Marr HB, Ramirez PW.   +9 more
europepmc   +1 more source

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine. [PDF]

Vaccines (Basel)
Xu D, Li JD, An J, Ma XX, Wang XL, Zhou Z, Liu HP, Diao MJ, Jiang YX, Zhou LY, Tong X, Zhou CL.   +11 more
europepmc   +1 more source

Exploring the Effects of Intersubunit Interface Mutations on Virus-Like Particle Structure and Stability. [PDF]

Biochemistry
Pistono PE, Xu J, Huang P, Fetzer JL, Francis MB.   +4 more
europepmc   +1 more source

Emerging trends in virus and virus-like particle gene therapy delivery to the brain. [PDF]

Mol Ther Nucleic Acids
Mandalawatta HP, Rajendra KC, Fairfax K, Hewitt AW.   +3 more
europepmc   +1 more source

A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology. [PDF]

Protein Sci
Lehky M, Moonian T, Michel T, Junker D, Müsken M, Strömpl J, Nübling P, Neumann F, Krumbholz A, Krause G, Schneiderhan-Marra N, van den Heuvel J, Strengert M.   +12 more
europepmc   +1 more source

Strengthening global health resilience: Marburg virus-like particle vaccines and the One Health approach. [PDF]

Sci One Health
Khadka RB, Karki K, Pandey J, Gyawali R, Chaudhary GP.   +4 more
europepmc   +1 more source

The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide. [PDF]

Hum Vaccin Immunother
Wang Z, Zhang T, Xu X.
europepmc   +1 more source

Targeting of phosphorylated tau at threonine 181 by a Qβ virus-like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques. [PDF]

Alzheimers Dement
Maphis NM, Hulse J, Peabody J, Dadras S, Whelpley MJ, Kandath M, Wilson C, Hobson S, Thompson J, Poolsup S, Beckman D, Ott SP, Watanabe JW, Usachenko JL, Van Rompay KK, Morrison J, Selwyn R, Rosenberg G, Knoefel J, Chackerian B, Bhaskar K.   +20 more
europepmc   +1 more source